Page last updated: 2024-09-04

cd 437 and Acne

cd 437 has been researched along with Acne in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arlabosse, JM; Bouix-Peter, C; Chambon, S; Chantalat, L; Daver, S; Dumais, L; Duvert, G; Feret, A; Ouvry, G; Pascau, J; Portal, T; Raffin, C; Rodeville, N; Soulet, C; Tabet, S; Talano, S; Thoreau, E	1

Other Studies

1 other study(ies) available for cd 437 and Acne

Article	Year
Structure-based design of Trifarotene (CD5789), a potent and selective RARγ agonist for the treatment of acne. Bioorganic & medicinal chemistry letters, 2018, 06-01, Volume: 28, Issue:10 Topics: Acne Vulgaris; Dose-Response Relationship, Drug; Drug Design; Humans; Molecular Docking Simulation; Molecular Structure; Receptors, Retinoic Acid; Retinoic Acid Receptor gamma; Retinoids; Structure-Activity Relationship	2018

Article

Year

Structure-based design of Trifarotene (CD5789), a potent and selective RARγ agonist for the treatment of acne.

Bioorganic & medicinal chemistry letters, 2018, 06-01, Volume: 28, Issue:10

Topics: Acne Vulgaris; Dose-Response Relationship, Drug; Drug Design; Humans; Molecular Docking Simulation; Molecular Structure; Receptors, Retinoic Acid; Retinoic Acid Receptor gamma; Retinoids; Structure-Activity Relationship

2018